词条 | Orciprenaline |
释义 |
| Verifiedfields = changed | verifiedrevid = 408782146 | IUPAC_name = (RS)-5-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,3-diol | image = Orciprenaline.svg | width = | chirality = Racemic mixture | USAN = Metaproterenol | tradename = | Drugs.com = [https://www.drugs.com/monograph/metaproterenol-sulfate.html monograph] | MedlinePlus = a682084 | pregnancy_AU = A | pregnancy_US = C | legal_US = Rx-only | routes_of_administration = Inhalation (MDI) and tablets | bioavailability = 3% if inhaled, 40% if taken orally | protein_bound = | metabolism = Gastrointestinal and hepatic | elimination_half-life = 6 hours | IUPHAR_ligand = 7250 | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 586-06-1 | ATC_prefix = R03 | ATC_suffix = AB03 | ATC_supplemental = {{ATC|R03|CB03}} {{ATC|R03|CB53}} | PubChem = 4086 | DrugBank_Ref = {{drugbankcite|changed|drugbank}} | DrugBank = DB00816 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 3944 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 53QOG569E0 | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D08300 | ChEBI_Ref = {{ebicite|changed|EBI}} | ChEBI = 82719 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 776 | C=11 | H=17 | N=1 | O=3 | molecular_weight = 211.258 g/mol | smiles = Oc1cc(cc(O)c1)C(O)CNC(C)C | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = LMOINURANNBYCM-UHFFFAOYSA-N | solubility = 9.7 }} Orciprenaline, also known as metaproterenol, is a bronchodilator used in the treatment of asthma.[1][2] Orciprenaline is a moderately selective β2 adrenergic receptor agonist that stimulates receptors of the smooth muscle in the lungs, uterus, and vasculature supplying skeletal muscle, with minimal or no effect on α adrenergic receptors. The pharmacologic effects of β adrenergic agonist drugs, such as orciprenaline, are at least in part attributable to stimulation through β adrenergic receptors of intracellular adenylyl cyclase, the enzyme which catalyzes the conversion of ATP to cAMP. Increased cAMP levels are associated with relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from many cells, especially from mast cells. Possible side effects
Brand names
References1. ^{{cite journal |title = DrugBank 3.0: a comprehensive resource for omics research on drugs |vauthors=Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS |journal = Nucleic Acids Res. |year = 2011 |volume = 39 |issue = Database issue |pages = D1035-41 | pmid =21059682 |doi=10.1093/nar/gkq1126 |pmc=3013709}} {{Asthma_and_copd rx}}{{Adrenergics}}{{Phenethylamines}}{{respiratory-system-drug-stub}}2. ^{{cite journal |title = DrugBank: a knowledgebase for drugs, drug actions and drug targets |vauthors=Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M |journal = Nucleic Acids Res |year = 2008 |volume = 36 |issue = Database issue |pages = D901-6 |pmid = 18048412 |doi=10.1093/nar/gkm958 |pmc=2238889}} 3 : Chemical substances for emergency medicine|Phenethylamines|Bronchodilators |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。